Skip to main content
  • Sign in
    Welcome !
    My account
    Logout

GERON CORP (GERN) Stock Forecast 2025 - AI Price Prediction & Analysis

GERON CORP (GERN) AI Stock Price Forecast & Investment Analysis

GERON CORP Stock Price Chart and Technical Analysis

Loading GERON CORP interactive price chart and technical analysis...

GERON CORP (GERN) - Comprehensive Stock Analysis & Investment Research

Deep dive into GERON CORP's business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Understanding Company Overview

What this section covers: Essential business information about GERON CORP, including sector classification, industry positioning, and organizational structure.

How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.

For GERON CORP: GERON CORP operates in the Life Sciences sector, making it an emerging small-cap investment.

GERON CORP (Stock Symbol: GERN) is a leading company in the Life Sciences sector , specifically operating within the Pharmaceutical Preparations industry.

The organization employs approximately 291 professionals worldwide .

The company has established itself as an emerging investment opportunity with substantial growth potential.

Understanding Financial Performance

What these metrics mean: Key financial indicators showing GERON CORP's revenue scale, profitability, market value, and shareholder returns.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For GERON CORP:

Market Capitalization: $833 million - Classified as a small-cap investment offering high growth potential.

Return on Equity (ROE): -79.3% - Below-average shareholder return efficiency, indicating areas for operational improvement.

Understanding AI Stock Predictions

What these predictions mean: AI-powered forecasts for GERON CORP stock using machine learning algorithms trained on historical market data and technical indicators.

How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Spearman correlation coefficient shows the statistical relationship between predictions and actual outcomes.

For GERON CORP: Unlock premium access to view detailed AI predictions and price targets.

🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for GERON CORP stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.

Understanding Market Position

What this analysis covers: GERON CORP's competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.

How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.

For GERON CORP: Market positioning analysis based on available financial and operational metrics.

GERON CORP strategically competes in the highly dynamic Pharmaceutical Preparations marketplace, representing an emerging small-cap investment with substantial growth potential and market disruption capabilities .

The company maintains a healthy 1.6% gross margin, indicating strong pricing power and operational efficiency.

GERON CORP (GERN) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for GERON CORP stock analysis.

Loading GERON CORP comprehensive fundamental analysis and insider trading data...

Deep dive into GERON CORP's financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if GERON CORP stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For GERON CORP: With a P/E ratio of -11.86, the market sees the stock as potentially undervalued.

P/E Ratio -11.86x
P/B Ratio 3.21x
Market Cap $833M
Dividend Yield 43.54%
EPS $-0.31
Book Value/Share $0.39
FCF/Share $-0.27
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently GERON CORP converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For GERON CORP: An ROE of -79.3% indicates room for improvement in shareholder value creation.

ROE -79.3%
ROA -51.8%
ROIC -59.6%
Gross Margin 1.6%
Operating Margin -3971.3%
Net Margin -131090.4%
EBT Margin 26.3%
Tax Rate 8.6%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess GERON CORP's ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For GERON CORP: A current ratio of 3.77 indicates strong liquidity.

Current Ratio 3.77x
Quick Ratio 3.69x
D/E Ratio 0.56x
Financial Leverage 2.04x
Interest Coverage -25.5x
Working Capital $169M
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal GERON CORP's ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For GERON CORP: Free cash flow of $-97M indicates cash challenges that need attention.

Operating Cash Flow $-97M
Free Cash Flow $-97M
FCF/Sales 27.6%
CapEx/Sales 17.9%
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively GERON CORP uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For GERON CORP: An asset turnover of 0.01x suggests room for improvement in asset utilization.

Asset Turnover 0.01x
Receivables Turnover 19.5x
Inventory Turnover 3.5x
Fixed Assets Turnover 0.3x
Days Sales Outstanding 19 days
Days Inventory 106 days
Payables Period 41 days
Cash Conversion Cycle 84 days
Understanding Financial Statement Data

What these metrics mean: Key figures from GERON CORP's income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For GERON CORP:

Income Statement ($ Millions)
Operating Income $-19M
Net Income $-63M
R&D Expense $12M
SG&A Expense $14M
Balance Sheet Highlights (% Of Assets)
Total Current Assets 89%
Cash & Short-term Investments 84%
Total Liabilities 51%
Accounts Receivable 3%
Inventory 11%
Dividend & Shareholder Information
Dividends Per Share $0.59
Payout Ratio 21.1%
Shares Outstanding 666M
Growth Metrics (YoY)
EPS Growth -12.1%

Latest GERON CORP Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting GERON CORP (GERN) stock price and investment outlook.

, source: Nasdaq

(RTTNews) - Geron Corp. (GERN) posted a first quarter net loss of $19.8 million, or $0.03 per share, compared to a loss of $55.4 million, or $0.09 per share, prior year. Total net revenue was $39.6 ...

, source: MarketWatch

Geron Corp. Annual stock financials by MarketWatch. View the latest 1GERN financial statements, income statements and financial ratios.

, source: The New York Times

The company conducting the world’s first clinical trial of a therapy using human embryonic stem cells said that it was halting that trial and leaving the stem cell business entirely. By Andrew Pollack ...

, source: The Motley Fool

The U.S. Food and Drug Administration approved Geron's lead candidate on June 6, under the brand name Rytelo. Peak Rytelo sales could surpass $1 billion annually. Rytelo's safety profile could make ...

GERON CORP Competitors & Peer Analysis - Life Sciences Sector

Comparative analysis of GERON CORP against industry peers and competitors in the Life Sciences sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
AARD Unlock Forecast - 30 Days FREE Trial $260M x 1.9x
ABBV Unlock Forecast - 30 Days FREE Trial $403201M 107.4x 0.0x
ABCL Unlock Forecast - 30 Days FREE Trial $1707M -5.3x 1.7x
ABEO Unlock Forecast - 30 Days FREE Trial $271M -2.5x 1.7x
ABT Unlock Forecast - 30 Days FREE Trial $221448M 15.8x 4.4x
ABUS Unlock Forecast - 30 Days FREE Trial $864M -8.3x 10.4x
ACAD Unlock Forecast - 30 Days FREE Trial $3876M 16.2x 4.7x
ACET Unlock Forecast - 30 Days FREE Trial $82M -0.4x 0.6x
ACRS Unlock Forecast - 30 Days FREE Trial $259M -4.5x 2.0x
ACRV Unlock Forecast - 30 Days FREE Trial $57M -2.8x 0.4x
ACTU Unlock Forecast - 30 Days FREE Trial $153M x -24.1x
ACUT Unlock Forecast - 30 Days FREE Trial $25M x x
ACXP Unlock Forecast - 30 Days FREE Trial $10M -0.8x 2.8x
ADAG Unlock Forecast - 30 Days FREE Trial $104M x 2.7x
ADCT Unlock Forecast - 30 Days FREE Trial $496M -9.2x -1.3x
ADIL Unlock Forecast - 30 Days FREE Trial $8M -0.1x 1.4x
ADTX Unlock Forecast - 30 Days FREE Trial $1M 0.0x 0.1x
AGIO Unlock Forecast - 30 Days FREE Trial $2500M 3.7x 1.8x
AIMD Unlock Forecast - 30 Days FREE Trial $17M -0.4x 1.5x
AKBA Unlock Forecast - 30 Days FREE Trial $814M -5.4x 27.9x
AKRO Unlock Forecast - 30 Days FREE Trial $4304M -8.7x 4.2x
AKTX Unlock Forecast - 30 Days FREE Trial $52184M -2.0x 2038.0x
ALDX Unlock Forecast - 30 Days FREE Trial $309M -5.1x 5.6x
ALLR Unlock Forecast - 30 Days FREE Trial $21M -0.2x 1.7x
ALMS Unlock Forecast - 30 Days FREE Trial $317M x 0.7x
ALNY Unlock Forecast - 30 Days FREE Trial $62333M -224.3x 248.8x
ALT Unlock Forecast - 30 Days FREE Trial $345M -5.7x 2.1x
ALXO Unlock Forecast - 30 Days FREE Trial $80M -0.4x 1.3x
ALZN Unlock Forecast - 30 Days FREE Trial $7M -0.1x 1.3x
AMLX Unlock Forecast - 30 Days FREE Trial $1269M -1.5x 7.6x
AMPH Unlock Forecast - 30 Days FREE Trial $1129M 8.5x 2.5x
AMRN Unlock Forecast - 30 Days FREE Trial $7868M -4.5x 16.9x
AMRX Unlock Forecast - 30 Days FREE Trial $3313M 1010.7x 0.0x
ANAB Unlock Forecast - 30 Days FREE Trial $1010M -2.5x 23.8x
ANEB Unlock Forecast - 30 Days FREE Trial $109M -4.3x 8.1x
ANIP Unlock Forecast - 30 Days FREE Trial $1874M 103.2x 4.3x
ANNX Unlock Forecast - 30 Days FREE Trial $528M -4.1x 2.7x
ANRO Unlock Forecast - 30 Days FREE Trial $165M x 1.3x
APLS Unlock Forecast - 30 Days FREE Trial $3758M -13.6x 24.0x
APRE Unlock Forecast - 30 Days FREE Trial $9M -1.2x 0.7x
APUS Unlock Forecast - 30 Days FREE Trial $23M x 2.4x
AQST Unlock Forecast - 30 Days FREE Trial $689M -10.7x -6.9x
ARCT Unlock Forecast - 30 Days FREE Trial $268M -7.0x 1.2x
ARDX Unlock Forecast - 30 Days FREE Trial $1219M -21.3x 8.7x
ARQT Unlock Forecast - 30 Days FREE Trial $2353M -6.6x 16.9x
ARTL Unlock Forecast - 30 Days FREE Trial $3M -0.7x 42.0x
ARVN Unlock Forecast - 30 Days FREE Trial $698M -4.8x 1.2x
ARWR Unlock Forecast - 30 Days FREE Trial $5454M -4.7x 10.4x
ASBP Unlock Forecast - 30 Days FREE Trial $17M x x
ASMB Unlock Forecast - 30 Days FREE Trial $237M -1.5x 13.1x
ASRT Unlock Forecast - 30 Days FREE Trial $79M -0.2x 0.9x
ATAI Unlock Forecast - 30 Days FREE Trial $1320M -4.4x 9.2x
ATXI Unlock Forecast - 30 Days FREE Trial $2M -9.5x 0.6x
ATXS Unlock Forecast - 30 Days FREE Trial $708M -4.7x 2.7x
AUPH Unlock Forecast - 30 Days FREE Trial $1629M 26.0x 4.9x
AVBP Unlock Forecast - 30 Days FREE Trial $742M x 3.0x
AVDL Unlock Forecast - 30 Days FREE Trial $1796M -10.2x 19.8x
AVTX Unlock Forecast - 30 Days FREE Trial $190M -0.1x 1.8x
AXSM Unlock Forecast - 30 Days FREE Trial $6709M -19.9x 91.8x
BBIO Unlock Forecast - 30 Days FREE Trial $12330M -11.6x -5.4x
BCAX Unlock Forecast - 30 Days FREE Trial $945M x 2.2x
BCTX Unlock Forecast - 30 Days FREE Trial $22M -1.7x 1.3x
BCYC Unlock Forecast - 30 Days FREE Trial $577M -6.0x 0.9x
BEIGF Unlock Forecast - 30 Days FREE Trial $38633M x 10.3x
BFRG Unlock Forecast - 30 Days FREE Trial $14M -2.9x 6.5x
BFRI Unlock Forecast - 30 Days FREE Trial $10M -0.1x 17.9x
BHC Unlock Forecast - 30 Days FREE Trial $2292M 24.1x -2.0x
BHVN Unlock Forecast - 30 Days FREE Trial $1825M -4.6x 13.6x
BIOA Unlock Forecast - 30 Days FREE Trial $283M x 1.0x
BIVI Unlock Forecast - 30 Days FREE Trial $4M -0.6x 0.2x
BLTE Unlock Forecast - 30 Days FREE Trial $2735M x 30.2x
BMEA Unlock Forecast - 30 Days FREE Trial $91M -1.6x 3.3x
BMRN Unlock Forecast - 30 Days FREE Trial $10275M 15.9x 1.7x
BMY Unlock Forecast - 30 Days FREE Trial $87310M 17.7x 5.0x
BMYMP Unlock Forecast - 30 Days FREE Trial $1498665M 296.8x 86.0x
BNTC Unlock Forecast - 30 Days FREE Trial $424M -0.6x 4.4x
BOLD Unlock Forecast - 30 Days FREE Trial $31M -15.1x 0.3x
BYSI Unlock Forecast - 30 Days FREE Trial $71M x -3.1x
CALC Unlock Forecast - 30 Days FREE Trial $45M 0.4x 7.4x
CAMP Unlock Forecast - 30 Days FREE Trial $59M -0.1x 1.5x
CANF Unlock Forecast - 30 Days FREE Trial $1984M x 474.1x
CARM Unlock Forecast - 30 Days FREE Trial $2M -0.7x 0.0x
CASI Unlock Forecast - 30 Days FREE Trial $27M -1.4x 14.6x
CATX Unlock Forecast - 30 Days FREE Trial $213M -2.8x 0.8x
CBIO Unlock Forecast - 30 Days FREE Trial $174M -6.5x 1.3x
CDT Unlock Forecast - 30 Days FREE Trial $8M -0.7x 2.4x
CING Unlock Forecast - 30 Days FREE Trial $18M -0.6x 3.3x
CLCS Unlock Forecast - 30 Days FREE Trial $17M x x
CLNN Unlock Forecast - 30 Days FREE Trial $79M -7.3x -6.9x
CLSD Unlock Forecast - 30 Days FREE Trial $298M -2.0x -0.7x
CLYM Unlock Forecast - 30 Days FREE Trial $157M -1.4x 0.9x
CMMB Unlock Forecast - 30 Days FREE Trial $1374M 10.9x 141.7x
CMPS Unlock Forecast - 30 Days FREE Trial $617M 0.0x 3.8x
CNSP Unlock Forecast - 30 Days FREE Trial $5M 0.0x 0.4x
CNTA Unlock Forecast - 30 Days FREE Trial $3276M -11.0x 9.5x
CNTB Unlock Forecast - 30 Days FREE Trial $96M x 1.4x
CNTX Unlock Forecast - 30 Days FREE Trial $129M -1.5x 1.6x
COGT Unlock Forecast - 30 Days FREE Trial $1846M -3.7x 11.9x
CORT Unlock Forecast - 30 Days FREE Trial $8724M 50.6x 13.7x
COYA Unlock Forecast - 30 Days FREE Trial $105M -6.8x 3.7x
CPHI Unlock Forecast - 30 Days FREE Trial $6M -0.2x 0.9x
CPIX Unlock Forecast - 30 Days FREE Trial $52M -4.5x 1.9x
CPRX Unlock Forecast - 30 Days FREE Trial $2618M 12.3x 3.1x
CRMD Unlock Forecast - 30 Days FREE Trial $847M 14.9x 3.8x
CRNX Unlock Forecast - 30 Days FREE Trial $4174M -15.9x 3.6x
CRVO Unlock Forecast - 30 Days FREE Trial $66M -0.7x 2.0x
CRVS Unlock Forecast - 30 Days FREE Trial $572M -13.7x 7.1x
CTMX Unlock Forecast - 30 Days FREE Trial $365M 7.7x 3.0x
CTNM Unlock Forecast - 30 Days FREE Trial $213M x 1.1x
CTOR Unlock Forecast - 30 Days FREE Trial $122M 3.9x 3.8x
CTXR Unlock Forecast - 30 Days FREE Trial $21M -5.3x 0.3x
CVKD Unlock Forecast - 30 Days FREE Trial $27M -11.1x 6.4x
CVSI Unlock Forecast - 30 Days FREE Trial $7M x 4.1x
CYDY Unlock Forecast - 30 Days FREE Trial $310M 86.7x x
CYRX Unlock Forecast - 30 Days FREE Trial $469M 7.2x 0.9x
CYTK Unlock Forecast - 30 Days FREE Trial $7M -9.4x -13.9x
DARE Unlock Forecast - 30 Days FREE Trial $18M 2.9x -2.3x
DAWN Unlock Forecast - 30 Days FREE Trial $753M -8.9x 1.6x
DERM Unlock Forecast - 30 Days FREE Trial $171M 24.1x 8.9x
DMAC Unlock Forecast - 30 Days FREE Trial $292M -4.2x 10.8x
DNTH Unlock Forecast - 30 Days FREE Trial $1080M -3.2x 3.6x
DRMA Unlock Forecast - 30 Days FREE Trial $3M -0.2x 0.5x
DRRX Unlock Forecast - 30 Days FREE Trial $59M -1.2x 17.0x
DSGN Unlock Forecast - 30 Days FREE Trial $380M -7.6x 1.8x
DVAX Unlock Forecast - 30 Days FREE Trial $1218M 88.2x 2.5x
DWTX Unlock Forecast - 30 Days FREE Trial $11M -2.9x 1.6x
DYN Unlock Forecast - 30 Days FREE Trial $2764M -7.8x 4.8x
EBS Unlock Forecast - 30 Days FREE Trial $515M 3.8x 1.0x
ELAN Unlock Forecast - 30 Days FREE Trial $10986M 25.4x 1.6x
ELTP Unlock Forecast - 30 Days FREE Trial $652M x 13.7x
ELVN Unlock Forecast - 30 Days FREE Trial $1247M -13.3x 2.6x
ENLV Unlock Forecast - 30 Days FREE Trial $25M x 1.3x
ENTA Unlock Forecast - 30 Days FREE Trial $224M -1.3x 2.8x
ENTO Unlock Forecast - 30 Days FREE Trial $24M 0.0x 0.3x
EOLS Unlock Forecast - 30 Days FREE Trial $455M -13.1x -89.8x
EPIX Unlock Forecast - 30 Days FREE Trial $9M -2.7x 0.1x
ERAS Unlock Forecast - 30 Days FREE Trial $699M -3.1x 1.9x
ESPR Unlock Forecast - 30 Days FREE Trial $597M -4.2x -0.2x
ETNB Unlock Forecast - 30 Days FREE Trial $2199M -3.5x 4.2x
ETON Unlock Forecast - 30 Days FREE Trial $506M -66.2x 21.1x
EWTX Unlock Forecast - 30 Days FREE Trial $1689M -19.7x 2.9x
FBLG Unlock Forecast - 30 Days FREE Trial $15M x 17.6x
FGEN Unlock Forecast - 30 Days FREE Trial $42M -0.2x -3.6x
FHTX Unlock Forecast - 30 Days FREE Trial $248M -3.3x -5.5x
FLGC Unlock Forecast - 30 Days FREE Trial $406M -4.2x 101.0x
FOLD Unlock Forecast - 30 Days FREE Trial $2736M -8.5x 13.4x
FULC Unlock Forecast - 30 Days FREE Trial $543M -36.1x 2.5x
GALT Unlock Forecast - 30 Days FREE Trial $329M -2.4x -1.6x
GBIO Unlock Forecast - 30 Days FREE Trial $42M -0.6x 0.8x
GERN Unlock Forecast - 30 Days FREE Trial $833M -11.9x 3.2x
GLMD Unlock Forecast - 30 Days FREE Trial $7M x 0.4x
GLSI Unlock Forecast - 30 Days FREE Trial $125M -17.2x 87.1x
GLTO Unlock Forecast - 30 Days FREE Trial $13M -2.5x 1.2x
GNLX Unlock Forecast - 30 Days FREE Trial $295M -2.8x 12.4x
GOSS Unlock Forecast - 30 Days FREE Trial $542M -3.2x -61.8x
GPCR Unlock Forecast - 30 Days FREE Trial $4975M -44.0x 6.4x
GRCE Unlock Forecast - 30 Days FREE Trial $43M -3.9x 0.7x
GRTX Unlock Forecast - 30 Days FREE Trial $1M -0.3x -0.1x
GYRE Unlock Forecast - 30 Days FREE Trial $715M 82.9x 7.8x
HCM Unlock Forecast - 30 Days FREE Trial $12966M x 10.6x
HMDCF Unlock Forecast - 30 Days FREE Trial $3194M x 2.6x
HOOK Unlock Forecast - 30 Days FREE Trial $11M -1.0x 0.3x
HOTH Unlock Forecast - 30 Days FREE Trial $19M -0.5x 1.9x
HOWL Unlock Forecast - 30 Days FREE Trial $73M -1.3x 1.8x
HRMY Unlock Forecast - 30 Days FREE Trial $1732M 9.6x 2.2x
HRTX Unlock Forecast - 30 Days FREE Trial $235M -6.4x -10.1x
IBIO Unlock Forecast - 30 Days FREE Trial $16M -0.4x 1.1x
IBO Unlock Forecast - 30 Days FREE Trial $7M x 6.5x
IDYA Unlock Forecast - 30 Days FREE Trial $2837M -12.2x 3.0x
IGC Unlock Forecast - 30 Days FREE Trial $34M -4.6x 5.5x
IMNM Unlock Forecast - 30 Days FREE Trial $1444M -2.4x 5.4x
IMRX Unlock Forecast - 30 Days FREE Trial $228M -0.8x 7.9x
IMUC Unlock Forecast - 30 Days FREE Trial $4M x 1.1x
IMUX Unlock Forecast - 30 Days FREE Trial $79M -0.8x 2.3x
INDP Unlock Forecast - 30 Days FREE Trial $2M -0.6x 66.4x
INDV Unlock Forecast - 30 Days FREE Trial $3098M 48.3x x
INM Unlock Forecast - 30 Days FREE Trial $4M -51.8x 0.3x
INO Unlock Forecast - 30 Days FREE Trial $86M -0.6x 3.0x
INSM Unlock Forecast - 30 Days FREE Trial $34894M -14.0x 27.9x
INVA Unlock Forecast - 30 Days FREE Trial $1122M 28.9x 2.0x
IOBT Unlock Forecast - 30 Days FREE Trial $43M -0.7x 27.1x
IONS Unlock Forecast - 30 Days FREE Trial $11712M -14.6x 18.5x
IRD Unlock Forecast - 30 Days FREE Trial $112M -2.0x 6.4x
IRON Unlock Forecast - 30 Days FREE Trial $3110M -18.4x 5.1x
IRWD Unlock Forecast - 30 Days FREE Trial $250M 64.7x -0.4x
ISCO Unlock Forecast - 30 Days FREE Trial $1M x x
IXHL Unlock Forecast - 30 Days FREE Trial $6M x 0.8x
JANX Unlock Forecast - 30 Days FREE Trial $1622M -63.7x 1.6x
JAZZ Unlock Forecast - 30 Days FREE Trial $8511M 14.3x 2.3x
JBIO Unlock Forecast - 30 Days FREE Trial $319M x 1.6x
JNJ Unlock Forecast - 30 Days FREE Trial $453268M 18.4x 5.7x
JUNS Unlock Forecast - 30 Days FREE Trial $55M x 41.3x
KALA Unlock Forecast - 30 Days FREE Trial $9M -0.5x 6.5x
KALV Unlock Forecast - 30 Days FREE Trial $562M -2.6x 13.8x
KAPA Unlock Forecast - 30 Days FREE Trial $21M x 3.4x
KNSA Unlock Forecast - 30 Days FREE Trial $3126M -64.7x 6.3x
KPRX Unlock Forecast - 30 Days FREE Trial $9M -2.4x 0.4x
KPTI Unlock Forecast - 30 Days FREE Trial $51M -0.6x -0.2x
KROS Unlock Forecast - 30 Days FREE Trial $623M -13.3x 0.9x
KRRO Unlock Forecast - 30 Days FREE Trial $376M -7.9x 1.6x
KURA Unlock Forecast - 30 Days FREE Trial $936M -4.5x 3.1x
KZR Unlock Forecast - 30 Days FREE Trial $47M -3.2x 0.5x
LEXX Unlock Forecast - 30 Days FREE Trial $16M -29.3x 2.9x
LIANY Unlock Forecast - 30 Days FREE Trial $7M x 0.0x
LIFD Unlock Forecast - 30 Days FREE Trial $4M x 0.1x
LIPO Unlock Forecast - 30 Days FREE Trial $3M -3.3x 1.0x
LLY Unlock Forecast - 30 Days FREE Trial $738254M 53.9x 40.4x
LQDA Unlock Forecast - 30 Days FREE Trial $1954M -7.2x 128.7x
LRMR Unlock Forecast - 30 Days FREE Trial $279M -0.8x 2.3x
LSTA Unlock Forecast - 30 Days FREE Trial $21M -1.0x 1.0x
LTRN Unlock Forecast - 30 Days FREE Trial $43M -2.4x 3.4x
LVTX Unlock Forecast - 30 Days FREE Trial $39M x 2.0x
LXRX Unlock Forecast - 30 Days FREE Trial $499M -1.2x 3.9x
LYEL Unlock Forecast - 30 Days FREE Trial $248M -1.1x 0.8x
MAIA Unlock Forecast - 30 Days FREE Trial $41M -1.4x 10.5x
MBIO Unlock Forecast - 30 Days FREE Trial $5M -0.1x 1.8x
MBX Unlock Forecast - 30 Days FREE Trial $592M x 2.7x
MDCX Unlock Forecast - 30 Days FREE Trial $38M x x
MDCXW Unlock Forecast - 30 Days FREE Trial $40M x x
MDGL Unlock Forecast - 30 Days FREE Trial $9684M -5.7x 13.9x
MGNX Unlock Forecast - 30 Days FREE Trial $104M -2.1x 2.2x
MIRA Unlock Forecast - 30 Days FREE Trial $28M -1.6x 49.4x
MIRM Unlock Forecast - 30 Days FREE Trial $3583M -20.0x 14.0x
MIST Unlock Forecast - 30 Days FREE Trial $104M -2.0x 4.2x
MLTX Unlock Forecast - 30 Days FREE Trial $630M -50.8x 1.8x
MLYS Unlock Forecast - 30 Days FREE Trial $2666M -4.5x 8.5x
MNKD Unlock Forecast - 30 Days FREE Trial $1660M 49.6x -20.2x
MNPR Unlock Forecast - 30 Days FREE Trial $488M -3.0x 9.3x
MREO Unlock Forecast - 30 Days FREE Trial $1667M x 30.8x
MRK Unlock Forecast - 30 Days FREE Trial $219490M 13.4x 4.5x
MRKR Unlock Forecast - 30 Days FREE Trial $12M -0.6x 1.1x
MRSN Unlock Forecast - 30 Days FREE Trial $49M -3.4x -1.4x
MRUS Unlock Forecast - 30 Days FREE Trial $7148M -13.5x 8.5x
MRVI Unlock Forecast - 30 Days FREE Trial $483M -5.6x 1.8x
MTSR Unlock Forecast - 30 Days FREE Trial $5470M x 12.2x
MTVA Unlock Forecast - 30 Days FREE Trial $24M -0.5x 2.5x
MURA Unlock Forecast - 30 Days FREE Trial $36M x 0.6x
NAMS Unlock Forecast - 30 Days FREE Trial $4055M x 5.2x
NAMSW Unlock Forecast - 30 Days FREE Trial $2773M x 3.6x
NATR Unlock Forecast - 30 Days FREE Trial $244M 17.6x 1.6x
NEUP Unlock Forecast - 30 Days FREE Trial $29M x 1.1x
NGNE Unlock Forecast - 30 Days FREE Trial $427M -7.3x 1.6x
NIKA Unlock Forecast - 30 Days FREE Trial $308M x x
NKTR Unlock Forecast - 30 Days FREE Trial $763M -1.2x 337.9x
NKTX Unlock Forecast - 30 Days FREE Trial $170M -1.3x 0.5x
NLSP Unlock Forecast - 30 Days FREE Trial $11M x 21.2x
NLSPW Unlock Forecast - 30 Days FREE Trial $0M x 0.3x
NRIX Unlock Forecast - 30 Days FREE Trial $939M -7.4x 2.5x
NRSN Unlock Forecast - 30 Days FREE Trial $29M x x
NTHI Unlock Forecast - 30 Days FREE Trial $169M x x
NUVB Unlock Forecast - 30 Days FREE Trial $1757M -1.2x 4.7x
NUVL Unlock Forecast - 30 Days FREE Trial $7008M -30.9x 7.5x
NVCT Unlock Forecast - 30 Days FREE Trial $147M -3.9x 8.7x
NWBO Unlock Forecast - 30 Days FREE Trial $366M x x
NXEN Unlock Forecast - 30 Days FREE Trial $1M x x
OCEA Unlock Forecast - 30 Days FREE Trial $0M -0.3x 0.0x
OCUL Unlock Forecast - 30 Days FREE Trial $1997M -8.2x 6.5x
OGN Unlock Forecast - 30 Days FREE Trial $1835M 3.4x 2.5x
OKUR Unlock Forecast - 30 Days FREE Trial $37M -6.9x 0.5x
OLMA Unlock Forecast - 30 Days FREE Trial $613M -4.0x 1.8x
OMER Unlock Forecast - 30 Days FREE Trial $478M -4.2x -0.9x
ONC Unlock Forecast - 30 Days FREE Trial $452526M x 120.0x
OPK Unlock Forecast - 30 Days FREE Trial $1030M -3.5x 0.8x
ORGO Unlock Forecast - 30 Days FREE Trial $539M -32.9x 2.3x
ORIC Unlock Forecast - 30 Days FREE Trial $1185M -4.2x 3.7x
ORKA Unlock Forecast - 30 Days FREE Trial $1027M x 3.0x
OSTX Unlock Forecast - 30 Days FREE Trial $55M x 11.1x
OTLC Unlock Forecast - 30 Days FREE Trial $41M x 4.9x
OVID Unlock Forecast - 30 Days FREE Trial $116M -2.6x 2.1x
OWPC Unlock Forecast - 30 Days FREE Trial $2M x x
PAHC Unlock Forecast - 30 Days FREE Trial $1696M 35.7x 5.9x
PBH Unlock Forecast - 30 Days FREE Trial $3110M 14.6x 1.7x
PBYI Unlock Forecast - 30 Days FREE Trial $273M 5.6x 2.6x
PCRX Unlock Forecast - 30 Days FREE Trial $947M -7534.1x 1.3x
PDSB Unlock Forecast - 30 Days FREE Trial $43M -1.7x 2.7x
PEPG Unlock Forecast - 30 Days FREE Trial $160M -1.6x 2.3x
PFE Unlock Forecast - 30 Days FREE Trial $139846M 13.1x 1.6x
PGEN Unlock Forecast - 30 Days FREE Trial $1255M -1.4x -37.0x
PHAT Unlock Forecast - 30 Days FREE Trial $919M -1.6x -1.6x
PMHS Unlock Forecast - 30 Days FREE Trial $6M x 0.7x
PMN Unlock Forecast - 30 Days FREE Trial $14M -2.1x 2.1x
PMVP Unlock Forecast - 30 Days FREE Trial $74M -1.6x 0.5x
PPCB Unlock Forecast - 30 Days FREE Trial $18M x 1.0x
PRAX Unlock Forecast - 30 Days FREE Trial $3938M -4.0x 9.7x
PRFX Unlock Forecast - 30 Days FREE Trial $4M x x
PRGO Unlock Forecast - 30 Days FREE Trial $3019M -27.6x 0.7x
PRTA Unlock Forecast - 30 Days FREE Trial $574M -12.4x 1.8x
PTCT Unlock Forecast - 30 Days FREE Trial $5325M 8.4x -20.3x
PTGX Unlock Forecast - 30 Days FREE Trial $4674M 87.7x 7.0x
PVCT Unlock Forecast - 30 Days FREE Trial $32M x x
PVLA Unlock Forecast - 30 Days FREE Trial $797M x 16.7x
PYXS Unlock Forecast - 30 Days FREE Trial $215M -1.3x 2.5x
QNRX Unlock Forecast - 30 Days FREE Trial $307M x 120.1x
QURE Unlock Forecast - 30 Days FREE Trial $3726M -2.8x 24.4x
RAPP Unlock Forecast - 30 Days FREE Trial $970M x 3.7x
RAPT Unlock Forecast - 30 Days FREE Trial $815M -0.4x 5.0x
RARE Unlock Forecast - 30 Days FREE Trial $3402M -7.0x 22.5x
RCKT Unlock Forecast - 30 Days FREE Trial $428M -4.8x 1.2x
RCUS Unlock Forecast - 30 Days FREE Trial $1979M -5.5x 3.6x
REGN Unlock Forecast - 30 Days FREE Trial $71273M 14.2x 2.3x
REVB Unlock Forecast - 30 Days FREE Trial $2M -0.1x 0.5x
RFL Unlock Forecast - 30 Days FREE Trial $34M -0.9x 0.4x
RIGL Unlock Forecast - 30 Days FREE Trial $558M 5.7x 6.8x
RLYB Unlock Forecast - 30 Days FREE Trial $22M -0.7x 0.5x
RMTI Unlock Forecast - 30 Days FREE Trial $40M -17.1x 1.3x
RNA Unlock Forecast - 30 Days FREE Trial $8454M -12.2x 7.1x
RNAC Unlock Forecast - 30 Days FREE Trial $216M -2.1x -14.1x
RNAZ Unlock Forecast - 30 Days FREE Trial $13M -0.2x 2.1x
RNXT Unlock Forecast - 30 Days FREE Trial $41M -3.4x 3.9x
ROIV Unlock Forecast - 30 Days FREE Trial $12560M 1.8x 2.9x
RPRX Unlock Forecast - 30 Days FREE Trial $20759M 20.8x 3.3x
RPTX Unlock Forecast - 30 Days FREE Trial $79M -2.1x 0.7x
RTSL Unlock Forecast - 30 Days FREE Trial $0M 0.5x x
RVPH Unlock Forecast - 30 Days FREE Trial $39M -4.1x -4.3x
RYTM Unlock Forecast - 30 Days FREE Trial $7130M -20.3x 2603.1x
RZLT Unlock Forecast - 30 Days FREE Trial $813M -3.9x 5.0x
SAVA Unlock Forecast - 30 Days FREE Trial $208M -1.9x 2.4x
SCNX Unlock Forecast - 30 Days FREE Trial $9M 2.9x 0.1x
SCPH Unlock Forecast - 30 Days FREE Trial $302M -2.0x -50.9x
SCYX Unlock Forecast - 30 Days FREE Trial $30M -2.4x 0.7x
SDGR Unlock Forecast - 30 Days FREE Trial $1600M -7.8x 4.7x
SEPN Unlock Forecast - 30 Days FREE Trial $1001M x 2.7x
SER Unlock Forecast - 30 Days FREE Trial $50M 22.6x 27.8x
SGMT Unlock Forecast - 30 Days FREE Trial $237M x 1.8x
SION Unlock Forecast - 30 Days FREE Trial $1699M x 5.1x
SKYE Unlock Forecast - 30 Days FREE Trial $43M -0.7x 1.0x
SLGL Unlock Forecast - 30 Days FREE Trial $113M x 3.6x
SLN Unlock Forecast - 30 Days FREE Trial $1034M x 11.0x
SLNCF Unlock Forecast - 30 Days FREE Trial $227M x 2.4x
SLNO Unlock Forecast - 30 Days FREE Trial $3405M -18.5x 14.2x
SLS Unlock Forecast - 30 Days FREE Trial $201M -1.0x 7.7x
SMMT Unlock Forecast - 30 Days FREE Trial $14316M 104.1x 74.5x
SNDX Unlock Forecast - 30 Days FREE Trial $1128M -4.1x 7.2x
SNNC Unlock Forecast - 30 Days FREE Trial $0M x x
SNSE Unlock Forecast - 30 Days FREE Trial $15M -0.4x 0.5x
SPRO Unlock Forecast - 30 Days FREE Trial $127M -17.8x 3.9x
SPRY Unlock Forecast - 30 Days FREE Trial $944M -23.5x 4.9x
SRPT Unlock Forecast - 30 Days FREE Trial $2296M 162.5x 1.7x
STOK Unlock Forecast - 30 Days FREE Trial $1790M 33.7x 5.3x
SUPN Unlock Forecast - 30 Days FREE Trial $2959M 46.0x 2.8x
SVRA Unlock Forecast - 30 Days FREE Trial $761M -8.2x 6.3x
SXTP Unlock Forecast - 30 Days FREE Trial $2M -0.6x 0.9x
SYBX Unlock Forecast - 30 Days FREE Trial $21M 3.6x 1.7x
SYRE Unlock Forecast - 30 Days FREE Trial $1497M -0.7x 3.3x
TBPH Unlock Forecast - 30 Days FREE Trial $718M 55.2x 3.2x
TCRT Unlock Forecast - 30 Days FREE Trial $6M -1.0x 1.7x
TELO Unlock Forecast - 30 Days FREE Trial $48M x 99.6x
TERN Unlock Forecast - 30 Days FREE Trial $771M -5.1x 2.5x
TEVA Unlock Forecast - 30 Days FREE Trial $22925M -13.9x 3.4x
TEVJF Unlock Forecast - 30 Days FREE Trial $23192M x 3.4x
TGTX Unlock Forecast - 30 Days FREE Trial $5324M 87.3x 19.3x
TNGX Unlock Forecast - 30 Days FREE Trial $845M -2.8x 6.3x
TNXP Unlock Forecast - 30 Days FREE Trial $147M 0.0x 0.9x
TOVX Unlock Forecast - 30 Days FREE Trial $4M -0.4x 0.1x
TRAW Unlock Forecast - 30 Days FREE Trial $20M -0.6x 1.8x
TRDA Unlock Forecast - 30 Days FREE Trial $280M 6.9x 0.7x
TRVI Unlock Forecast - 30 Days FREE Trial $1296M -6.1x 6.5x
TVRD Unlock Forecast - 30 Days FREE Trial $44M x 1.3x
TYRA Unlock Forecast - 30 Days FREE Trial $780M -9.5x 2.6x
UPB Unlock Forecast - 30 Days FREE Trial $1305M x 3.2x
URGN Unlock Forecast - 30 Days FREE Trial $949M -2.5x -15.2x
UTHR Unlock Forecast - 30 Days FREE Trial $18780M 15.5x 2.6x
VERA Unlock Forecast - 30 Days FREE Trial $1921M -20.4x 4.1x
VINC Unlock Forecast - 30 Days FREE Trial $0M -0.2x 0.1x
VKTX Unlock Forecast - 30 Days FREE Trial $4040M -67.5x 5.7x
VNDA Unlock Forecast - 30 Days FREE Trial $330M -16.1x 0.7x
VRCA Unlock Forecast - 30 Days FREE Trial $38M -0.5x -4.1x
VRDN Unlock Forecast - 30 Days FREE Trial $1867M -4.5x 3.6x
VREOF Unlock Forecast - 30 Days FREE Trial $290M x 1.1x
VRNA Unlock Forecast - 30 Days FREE Trial $73547M -185.1x 264.3x
VRTX Unlock Forecast - 30 Days FREE Trial $108256M 29.8x 6.3x
VSTM Unlock Forecast - 30 Days FREE Trial $547M -6.5x 15.2x
VTGN Unlock Forecast - 30 Days FREE Trial $129M -0.1x 2.3x
VTRS Unlock Forecast - 30 Days FREE Trial $12170M -29.5x 0.0x
VTVT Unlock Forecast - 30 Days FREE Trial $0M -3.3x -7.5x
VTYX Unlock Forecast - 30 Days FREE Trial $279M -1.0x 1.3x
VYNE Unlock Forecast - 30 Days FREE Trial $7M -0.4x 0.2x
WHWK Unlock Forecast - 30 Days FREE Trial $104M x 0.6x
WVE Unlock Forecast - 30 Days FREE Trial $1186M -22.2x 8.5x
XBIT Unlock Forecast - 30 Days FREE Trial $76M -3.5x 0.4x
XENE Unlock Forecast - 30 Days FREE Trial $3223M -15.4x 5.1x
XERS Unlock Forecast - 30 Days FREE Trial $1475M 385.0x -23.8x
XLO Unlock Forecast - 30 Days FREE Trial $39M -0.5x 5.5x
XNCR Unlock Forecast - 30 Days FREE Trial $1018M -8.4x 1.6x
XOMA Unlock Forecast - 30 Days FREE Trial $419M -11.7x 5.8x
XOMAO Unlock Forecast - 30 Days FREE Trial $307M -10.1x 4.2x
XOMAP Unlock Forecast - 30 Days FREE Trial $320M -10.5x 4.4x
ZBIO Unlock Forecast - 30 Days FREE Trial $1241M x 5.2x
ZLAB Unlock Forecast - 30 Days FREE Trial $28951M -95.2x 36.6x
ZOMDF Unlock Forecast - 30 Days FREE Trial $62M x 0.5x
ZTS Unlock Forecast - 30 Days FREE Trial $64554M 24.9x 13.0x
ZVRA Unlock Forecast - 30 Days FREE Trial $615M -55.3x 5.3x
ZYME Unlock Forecast - 30 Days FREE Trial $1389M -8.3x 4.2x

Frequently Asked Questions - GERON CORP Stock Forecast

How accurate are GERON CORP stock predictions?

Our AI model shows a 35% Spearman correlation coefficient for GERN predictions, based on advanced machine learning algorithms trained on over 10 years of market data. This measures the strength of the monotonic relationship between predicted and actual price movements.

What factors influence GERON CORP stock price forecasts?

Our analysis considers GERON CORP's financial metrics, Life Sciences sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is GERON CORP a good investment in 2025?

Based on our AI analysis, GERON CORP shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are GERON CORP forecasts updated?

GERON CORP stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want More Advanced GERON CORP Analysis?

Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for GERON CORP stock.

🎯 Get Premium Analysis 📊 Explore More Stocks

My Portfolio

Investment Dashboard

Loading your portfolio...